CinDome Pharma Announces Start of Phase 2 Trial of Deuterated Domperidone (CIN-102)
19. September 2019 08:30 ET
|
CinRx Pharma
CINCINNATI, Sept. 19, 2019 (GLOBE NEWSWIRE) -- CinDome Pharma, Inc. (“CinDome”), a company whose lead product is deuterated domperidone (CIN-102), today announced that is has enrolled the first...